Cancer Research Meeting Calendar  Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dai, M.
Right arrow Articles by Franceschi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dai, M.
Right arrow Articles by Franceschi, S.
[Cancer Research 64, 468-471, January 15, 2004]
© 2004 American Association for Cancer Research


Advances in Brief

Human Papillomavirus Type 16 and TP53 Mutation in Oral Cancer

Matched Analysis of the IARC Multicenter Study

Min Dai1, Gary M. Clifford1, Florence le Calvez1, Xavier Castellsagué2, Peter J. F. Snijders3, Michael Pawlita4, Rolando Herrero1,5, Pierre Hainaut1 and Silvia Franceschi1 for the IARC Multicenter Oral Cancer Study Group

1 IARC, Lyon, France;
2 Institut Català d’Oncologia, Barcelona, Spain;
3 Vrije Universiteit Medical Center, Amsterdam, the Netherlands;
4 Deutsches Krebsforschungszentrum, Heidelberg, Germany; and
5 Costa Rican Foundation for Health Sciences, San José, Costa Rica

TP53 mutations were analyzed in 35 human papillomavirus (HPV) type 16 DNA-positive cancers of the oral cavity and oropharynx and in 35 HPV DNA-negative cancers matched by subsite, country, sex, age, and tobacco and alcohol consumption. Wild-type TP53 was found more frequently in cancer specimens that contained HPV16 DNA than in those that did not. All 14 HPV16 DNA-positive cancers in HPV16 E6 antibody-positive patients contained wild-type TP53, compared with 50% of corresponding HPV DNA-negative cancers (matched odds ratio, {infty}; 95% confidence interval, 1.4–{infty}). In contrast, for HPV16 DNA-positive cancers in E6-negative patients, wild-type TP53 frequency was similar to that in corresponding HPV DNA-negative cancers (matched odds ratio, 1.0; 95% confidence interval, 0.2–5.4). TP53 inactivation is a major mechanism of HPV-related carcinogenesis in the oral cavity and oropharynx. The role of HPV in cancers also containing TP53 mutations remains to be clarified.




This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
C. Fakhry, W. H. Westra, S. Li, A. Cmelak, J. A. Ridge, H. Pinto, A. Forastiere, and M. L. Gillison
Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial
J Natl Cancer Inst, February 20, 2008; 100(4): 261 - 269.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S Mitra, S Banerjee, C Misra, R K Singh, A Roy, A Sengupta, C K Panda, and S Roychoudhury
Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population
J. Clin. Pathol., September 1, 2007; 60(9): 1040 - 1047.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
B Perez-Ordonez, M Beauchemin, and R C K Jordan
Molecular biology of squamous cell carcinoma of the head and neck.
J. Clin. Pathol., May 1, 2006; 59(5): 445 - 453.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
P. M. Weinberger, Z. Yu, B. G. Haffty, D. Kowalski, M. Harigopal, J. Brandsma, C. Sasaki, J. Joe, R. L. Camp, D. L. Rimm, et al.
Molecular Classification Identifies a Subset of Human Papillomavirus-Associated Oropharyngeal Cancers With Favorable Prognosis
J. Clin. Oncol., February 10, 2006; 24(5): 736 - 747.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. J.C. Slebos, Y. Yi, K. Ely, J. Carter, A. Evjen, X. Zhang, Y. Shyr, B. M. Murphy, A. J. Cmelak, B. B. Burkey, et al.
Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell Carcinoma
Clin. Cancer Res., February 1, 2006; 12(3): 701 - 709.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
F. Le Calvez, A. Ahman, N. Tonisson, J. Lambert, S. Temam, P. Brennan, D. G. Zaridze, A. Metspalu, and P. Hainaut
Arrayed Primer Extension Resequencing of Mutations in the TP53 Tumor Suppressor Gene: Comparison with Denaturing HPLC and Direct Sequencing
Clin. Chem., July 1, 2005; 51(7): 1284 - 1287.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. R. Kreimer, G. M. Clifford, P. Boyle, and S. Franceschi
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 467 - 475.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
C. Ateenyi-Agaba, M. Dai, F. Le Calvez, E. Katongole-Mbidde, A. Smet, M. Tommasino, S. Franceschi, P. Hainaut, and E. Weiderpass
TP53 mutations in squamous-cell carcinomas of the conjunctiva: evidence for UV-induced mutagenesis
Mutagenesis, September 1, 2004; 19(5): 399 - 401.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
L. Mao and W. K. Hong
How Does Human Papillomavirus Contribute to Head and Neck Cancer Development?
J Natl Cancer Inst, July 7, 2004; 96(13): 978 - 980.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.